4//SEC Filing
Lee John Sang 4
Accession 0001169245-21-000008
CIK 0001169245other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:45 PM ET
Size
5.6 KB
Accession
0001169245-21-000008
Insider Transaction Report
Form 4
Lee John Sang
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-05+76,500→ 76,500 totalExercise: $4.31Exp: 2031-02-05→ Common Stock (76,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 5, 2021, subject to the reporting person's continued service through each such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001755665
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:45 PM ET
- Size
- 5.6 KB